Member Info for optimist13

Hi Kenny, no, haven't sold any as it was always intended as a longer term investment, but not this long!

The good thing is, the RTO is taking place this month and there should bee a lot more PR in the coming days, which will hopefully attract many more new investors.

I understand there are several more brokerage firms looking to offering online access to Aquis and there are also a couple of high profile listings coming to the Aquis Exchange as well.

With so few shares available, the price should continue to rise on relatively small purchases as I can't see anyone selling until after the RTO.

Good luck to all LTH's here, we certainly are due some good news.

Kenny, if Dr Barnhill delivers on the strategy set out in his presentation, the share price should do very well from this low level. you never know, we may even end up in profit!

I use Barclays. Link below of other brokers on Aquis:

https://www.aquis.eu/aquis-stock-exchange/for-investors/brokers

Over the ask being paid now:

01/03/21 | 08:50:56 30000 9.85

Message just received from my broker- Interactive Investors:

Thank you for your secure message.



The company trading on the AIM to be exempt
from stamp duty, need to apply for the exemption, unfortunately, Rambler Metals
and Mining have not applied, therefore, stamp duty is applicable.

Lots of Twitter updates from Apollon at the moment:

Apollon UK
@apollon_uk
·
8m
Apollon Formularies Managing Director @SteveBarnhillMD
expects lots of news flow due to a lot of exciting things going on with Apollon.

Watch the full Interview: https://youtu.be/LKk24HuN4SQ

Hi Kenny,

504750000 shares @24.25p = mkt cap of £122.4m

https://www.investegate.co.uk/aquis-exchange-plc--aqx-/rns/trading-and-operational-update/202102260700074273Q/

Extract:

Aquis Stock Exchange (AQSE), the Company's primary listings market for SMEs

Aquis is pleased to announce that Liberum, Panmure Gordon, Peel Hunt and Zeus Capital have joined Aquis Stock Exchange (AQSE) as corporate advisors, meaning these institutions are now able to prepare applications and assess the suitability of companies for admission to the AQSE Growth Market. This represents a further endorsement of the Company's aim to develop the exchange into the home of growth companies, and brings the total number of corporate advisers to AQSE to 28.

There is a strong IPO pipeline for 2021, including the listing of Samarkand Group. The cross-border eCommerce technology and retail group announced on 8 February its intention to float on AQSE, demonstrating our ability to compete with other UK exchanges in the IPO market.

As part of its strategy to transform the UK listings space, Aquis has also been participating in the UK Listings Review chaired by Lord Hill. This review was launched in November 2020 by the Chancellor, as part of a plan to strengthen the UK's position as a leading global finance centre.

The Aquis Stock Exchange rulebook changes implemented in December 2020 have been operating in practice for a number of weeks, with new admissions to the Apex market required to publish a growth prospectus, facilitating private investor participation in Apex IPOs.

Thanks Kenny. Definitely worth reading. Extract:
Medical Cannabis Exports

Dr Stephen Barnhill, CEO and Founder of Apollon, told BusinessCann it is excited by the prospects that lie ahead. “This is a big opportunity for us. we will be a public company that can handle THC. It’s very exciting.

“Apollon delivers high-end formulations of disease-specific products that are patient-specific. One of our aims is to secure the clinical data which can help get the world educated on how to use medical cannabis correctly.

https://businesscann.com/ground-breaking-jamaican-medical-cannabis-firm-the-latest-to-list-on-the-london-markets/

From the 26 February 2020 RNS:

"It is intended that the Company will acquire all the issued and outstanding shares from the shareholders of Apollon UK pursuant to a right of first refusal in consideration for the issue and allotment to those shareholders of new ordinary shares in the capital of the Company at a price of 10 pence per new ordinary share"

https://www.investegate.co.uk/afriag-global-plc--afri-/prn/update-on-apollon-uk-acquisition/20200226070000P6703/

The share price has been driven down because of poor performance by the Board to deliver on any of the promises/strategies and with the previous consolidation there are only 30+m shares in issue at the moment.

We know the terms of the fundraise to effect the RTO and there is plenty information on the plans for Apollon on the website and the recent interview with Dr Barnhill.

I think buying shares around the current price is a pretty safe bet and judging by the recent listings in the Cannabis market, the should be a good demand for shares.

Yes, he has certainly upset many people over the years, but as you say, it is best to do your own due diligence.

The information about Apollon is out there in the public domain and the funding to effect the RTO is now in place. Shareholders in AfriAg are sitting on huge losses, but new shareholders of the new company Apollon should do very well from the current levels. All IMHO, DYOR.

David Lenigas
@DavidLenigas
With Cellular Goods Plc flying this morning on its London listing as a new cannabis related stock, the market will soon look at the fully funded AfriAg and Apollon medical cannabis transaction. @CellularGoods
#CBX #AFRI. This CBX highlight the market sector potential in the UK

7 years and counting for me as far as AfriAg is concerned. Don't recall being in other stocks at the same time though.

I see not all of the trades are being shown on this site. Seen that a few companies that I hold:

25/02/21 | 16:02:35 1621 9.2499
25/02/21 | 16:02:32 23980 9.3
25/02/21 | 15:29:57 10555 9

I see Dr Barnhill's interview has now had over 1,500 views.

Think there could be more interest here tomorrow as listening to the interview and viewing Apollon's website gives a very good indication of how this company could grow and deliver meaningful revenues in the near term.

I think we are both watching this very closely on the expectation that we may finally see some reward for holding this share for so long. Also applies to others on here, but as you are aware I have a substantial holding.

9.30p paid....

Hopefully it will be a stampede and the stock will become much more liquid.

Some heavy hitters promoting the Aquis Exchange at the moment and the high profile launch of the new Cannabis companies on it will also help liquidity.

8.95p paid.........looking very promising, and very few shares available at the current time.

Full ask being paid...don't think it will take much to push this higher. Apollon appears to be getting positive reviews from many retail investors.